Literature DB >> 1322294

Human immunodeficiency virus infection of cells arrested in the cell cycle.

P Lewis1, M Hensel, M Emerman.   

Abstract

Cell proliferation is necessary for proviral integration and productive infection of most retroviruses. Nevertheless, the human immunodeficiency virus (HIV) can infect non-dividing macrophages. This ability to grow in non-dividing cells is not specific to macrophages because, as we show here, CD4+ HeLa cells arrested at stage G2 of the cell cycle can be infected by HIV-1. Proliferation is necessary for these same cells to be infected by a murine retrovirus, MuLV. HIV-1 integrates into the arrested cell DNA and produces viral RNA and protein in a pattern similar to that in normal cells. In addition, our data suggest that the ability to infect non-dividing cells is due to one of the HIV-1 core virion proteins. HIV infection of non-dividing cells distinguishes lentiviruses from other retroviruses and is likely to be important in the natural history of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322294      PMCID: PMC556788          DOI: 10.1002/j.1460-2075.1992.tb05376.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  40 in total

1.  Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.

Authors:  C M Farnet; W A Haseltine
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

2.  In vitro maturation of mononuclear phagocytes and susceptibility to HIV-1 infection.

Authors:  A Valentin; A Von Gegerfelt; S Matsuda; K Nilsson; B Asjö
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1991

3.  Cellular functions are required for the synthesis and integration of avian sarcoma virus-specific DNA.

Authors:  H E Varmus; T Padgett; S Heasley; G Simon; J M Bishop
Journal:  Cell       Date:  1977-06       Impact factor: 41.582

4.  Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy.

Authors:  S Koenig; H E Gendelman; J M Orenstein; M C Dal Canto; G H Pezeshkpour; M Yungbluth; F Janotta; A Aksamit; M A Martin; A S Fauci
Journal:  Science       Date:  1986-09-05       Impact factor: 47.728

5.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production.

Authors:  A D Miller; C Buttimore
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

Review 6.  Functional plasticity of microglia: a review.

Authors:  W J Streit; M B Graeber; G W Kreutzberg
Journal:  Glia       Date:  1988       Impact factor: 7.452

7.  Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.

Authors:  K Peden; M Emerman; L Montagnier
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

Review 8.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

9.  Replication of human immunodeficiency virus type 1 in primary dendritic cell cultures.

Authors:  E Langhoff; E F Terwilliger; H J Bos; K H Kalland; M C Poznansky; O M Bacon; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

10.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.

Authors:  J S McDougal; A Mawle; S P Cort; J K Nicholson; G D Cross; J A Scheppler-Campbell; D Hicks; J Sligh
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

View more
  210 in total

1.  A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.

Authors:  N Srinivasakumar; F G Schuening
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Separable mechanisms of attachment and cell uptake during retrovirus infection.

Authors:  S Sharma; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  The cellular mismatch repair system is able to repair mismatches within MLV retroviral double-stranded DNA at a low frequency.

Authors:  L Y Tang; J Zhang
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

5.  Infection of nondividing cells by Rous sarcoma virus.

Authors:  T Hatziioannou; S P Goff
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Somatic cell mutants resistant to retrovirus replication: intracellular blocks during the early stages of infection.

Authors:  G Gao; S P Goff
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

7.  The effect of viral regulatory protein expression on gene delivery by human immunodeficiency virus type 1 vectors produced in stable packaging cell lines.

Authors:  N Srinivasakumar; N Chazal; C Helga-Maria; S Prasad; M L Hammarskjöld; D Rekosh
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

8.  Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Authors:  Y Takeuchi; S H Liong; P D Bieniasz; U Jäger; C D Porter; T Friedman; M O McClure; R A Weiss
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

9.  Evidence that stable retroviral transduction and cell survival following DNA integration depend on components of the nonhomologous end joining repair pathway.

Authors:  René Daniel; James G Greger; Richard A Katz; Konstantin D Taganov; Xiaoyun Wu; John C Kappes; Anna Marie Skalka
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 10.  Clinical trials with retrovirus mediated gene therapy--what have we learned?

Authors:  Nikolai G Rainov; Huan Ren
Journal:  J Neurooncol       Date:  2003-12       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.